mounjaro

Generic: tirzepatide

Labeler: eli lilly and company
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name mounjaro
Generic Name tirzepatide
Labeler eli lilly and company
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

tirzepatide 12.5 mg/mL

Manufacturer
Eli Lilly and Company

Identifiers & Regulatory

Product NDC 0002-4210
Product ID 0002-4210_371ba02d-d590-4295-a315-b5efe4596614
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA215866
Listing Expiration 2027-12-31
Marketing Start 2026-01-07

Pharmacologic Class

Established (EPC)
glucose-dependent insulinotropic polypeptide receptor agonist [epc] glp-1 receptor agonist [epc]
Mechanism of Action
g-protein-linked receptor interactions [moa] glucagon-like peptide-1 (glp-1) agonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00024210
Hyphenated Format 0002-4210

Supplemental Identifiers

RxCUI
2601743 2601746 2601755 2601758 2601761 2601764 2601767 2601770 2601773 2601776 2601784 2601785 2644396 2644399 2644401 2644403 2644405 2644407 2644409 2644411 2644413 2644415 2644417 2644419 2732437 2732442 2732446 2732449 2732452 2732456 2733666 2733668 2733670 2733671 2733673 2733675 2734623 2734628 2734632 2734636 2734640 2734644 2735286 2735288 2735290 2735292 2735294 2735297
UPC
0300023002013 0300021152017 0300022423017 0300024612112 0300024052116 0300024304116 0300021243012 0300024523111
UNII
OYN3CCI6QE
NUI
N0000194015 N0000000152 N0000178480 N0000020058

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name mounjaro (source: ndc)
Generic Name tirzepatide (source: ndc)
Application Number NDA215866 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 12.5 mg/mL
source: ndc
Packaging
  • 1 VIAL, MULTI-DOSE in 1 CARTON (0002-4210-11) / 2.4 mL in 1 VIAL, MULTI-DOSE (0002-4210-01)
source: ndc

Packages (1)

0002-4210-11 1 VIAL, MULTI-DOSE in 1 CARTON (0002-4210-11) / 2.4 mL in 1 VIAL, MULTI-DOSE (0002-4210-01)

Ingredients (1)

tirzepatide (12.5 mg/mL)

Linked Drug Pages (1)

MOUNJARO, Mounjaro ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "371ba02d-d590-4295-a315-b5efe4596614", "openfda": {"nui": ["N0000194015", "N0000000152", "N0000178480", "N0000020058"], "upc": ["0300023002013", "0300021152017", "0300022423017", "0300024612112", "0300024052116", "0300024304116", "0300021243012", "0300024523111"], "unii": ["OYN3CCI6QE"], "rxcui": ["2601743", "2601746", "2601755", "2601758", "2601761", "2601764", "2601767", "2601770", "2601773", "2601776", "2601784", "2601785", "2644396", "2644399", "2644401", "2644403", "2644405", "2644407", "2644409", "2644411", "2644413", "2644415", "2644417", "2644419", "2732437", "2732442", "2732446", "2732449", "2732452", "2732456", "2733666", "2733668", "2733670", "2733671", "2733673", "2733675", "2734623", "2734628", "2734632", "2734636", "2734640", "2734644", "2735286", "2735288", "2735290", "2735292", "2735294", "2735297"], "spl_set_id": ["d2d7da5d-ad07-4228-955f-cf7e355c8cc0"], "pharm_class_epc": ["Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]", "GLP-1 Receptor Agonist [EPC]"], "pharm_class_moa": ["G-Protein-linked Receptor Interactions [MoA]", "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 CARTON (0002-4210-11)  / 2.4 mL in 1 VIAL, MULTI-DOSE (0002-4210-01)", "package_ndc": "0002-4210-11", "marketing_start_date": "20260107"}], "brand_name": "Mounjaro", "product_id": "0002-4210_371ba02d-d590-4295-a315-b5efe4596614", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["G-Protein-linked Receptor Interactions [MoA]", "GLP-1 Receptor Agonist [EPC]", "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]", "Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]"], "product_ndc": "0002-4210", "generic_name": "tirzepatide", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Mounjaro", "active_ingredients": [{"name": "TIRZEPATIDE", "strength": "12.5 mg/mL"}], "application_number": "NDA215866", "marketing_category": "NDA", "marketing_start_date": "20260107", "listing_expiration_date": "20271231"}